Help us make better tools for you!. Read more (Published: 2017-01-12)

KITE - Kite Pharma Tue 24'th Jan 2017

Industry: Biotechnology Sector: Healthcare
Add to Watchlist

Buy Candidate

Score: 4.46

#1192 of 5186
MV Long:
MV Short:
Accuracy: 89.19%
Risk: Medium
Request Prediction
We need your help. Please answer this short survey to help us improve by clicking HERE.

Stock analysis for Tue 24'th Jan 2017 (Updated daily)

Buy candidate since 2017-01-24

Kite Pharma Stock Analysis

Kite Pharma gained 4.51% in the last trading day, rising from USD 45.91 to USD 47.98. The price has been going up and down for this period, and there has been a -7.71% loss for the last 2 weeks. Volume also increased in the last day along with the price, which is a positive technical sign, and, in total, 87 601 more shares were traded than the day before. In total, 720 989 shares bought and sold for approximately USD 34.59 million.


Kite Pharma lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 3.7% during the next 3 months and, with 90% probability hold a price between USD 43.28 and USD 57.06 at the end of this period.


A buy signal was issued from a pivot bottom point on Monday January 23, 2017, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Kite Pharma holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general salessignal in the stock. On further gains, the stock will meet resistance from the long-term moving average at USD 48.47. On a fall, the stock will find some support from the short-term average at USD 47.60. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.

Relative Strength Index (RSI)

RSI14 is 57 and the stock is currently not being overbought or oversold

Support & Resistance

Kite Pharma finds support from accumulated volume at USD 46.82, USD 45.69, and USD 45.07. On the upside the stock meets some resistance just above today's level from accumulated volume at USD 49.61, USD 50.90 and USD 53.62.

The stock is about to test the resistance from accumulated volume at USD 49.61 and this may cause the stock to take a minor break or get into a more sideways move for a few days.


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved USD 2.69 between high and low, or 5.94%. For the last week, the stock has had a daily average volatility of 4.24%.

Our recommended stoploss: USD 45.66 (-4.84%) ( criteria: risk and position in trend)


Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Buy Candidate.

Buy Candidate

Want to be one step ahead of others?

Subscribe Now!

Click for pro features list

Want to be one step ahead of others?

Subscribe Now!

Click for pro features list

Chart Explanation

Build Your Watchlist

Add KITE My Watchlist

Weekly Trading Secrets

book of the week

Companies analyzed today